Tissium targets the nerve repair market with $68 million and a sutureless FDA-authorised device
Tissium has secured approximately $68 million to expand the U.S. rollout of Coaptium Connect, a light-activated polymer system for peripheral nerve repair. Its commercial opportunity is significant, but surgeon adoption and stronger comparative evidence remain crucial.